(Q40915145)

24 September 2017

1 reference

title

Growth factors in angiogenesis: current interest and therapeutic potential (English)

1 reference

24 September 2017

Colville-Nash PR

1

1 reference

24 September 2017

Willoughby DA

series ordinal

2

1 reference

24 September 2017

publication date

1 January 1997

1 reference

Trends in Molecular Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

3

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

14-23

1 reference

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Angiogenesis: models and modulators.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Regulators of Angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Angiogenic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

VEGF/VPF: the angiogenesis factor found?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Fibroblast growth factors: at the heart of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Acidic Fibroblast Growth Factor Accelerates the Healing of Acetic-Acid-lnduced Gastric Ulcers in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

The role of CXC chemokines as regulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Interleukin-8 as a macrophage-derived mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Angiogenesis promoters and inhibitors: potential therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2896%2910048-4

7 January 2021

10.1016/S1357-4310(96)10048-4

Identifiers

DOI

1 reference

24 September 2017

1 reference